دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke
Brian H. Buck, MD, MSc1; Michael D. Hill, MD2,3; F. Russell Quinn, MD4; et al
doi : 10.1001/jama.2021.6128
JAMA. 2021;325(21):2160-2168
Importance The relative rates of detection of atrial fibrillation (AF) or atrial flutter from evaluating patients with prolonged electrocardiographic monitoring with an external loop recorder or implantable loop recorder after an ischemic stroke are unknown.
Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease
Richard A. Bernstein, MD, PhD1; Hooman Kamel, MD2; Christopher B. Granger, MD3; Jonathan P. Piccini, MD3; Pramod P. Sethi, MD4,5; Jeffrey M. Katz, MD6,7; Carola Alfaro Vives, MS8; Paul D. Ziegler, MS8; Noreli C. Franco, PhD8; Lee H. Schwamm, MD9; for the STROKE-AF Investigators
doi : 10.1001/jama.2021.6470
JAMA. 2021;325(21):2169-2177.
Importance Patients with ischemic stroke attributed to large- or small-vessel disease are not considered at high risk for atrial fibrillation (AF), and the AF incidence rate in this population is unknown.
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis
Shunsuke Furuta, MD, PhD1; Daiki Nakagomi, MD, PhD2; Yoshihisa Kobayashi, MD, PhD3; Masaki Hiraguri, MD4; Takao Sugiyama, MD, PhD5; Koichi Amano, MD, PhD6; Takeshi Umibe, MD, PhD7; Hajime Kono, MD, PhD8; Kazuhiro Kurasawa, MD, PhD9; Yasuhiko Kita, MD, PhD10; Ryutaro Matsumura, MD, PhD11; Yuko Kaneko, MD, PhD12; Keita Ninagawa, MD13; Keiju Hiromura, MD, PhD14; Shin-ichiro Kagami, MD, PhD15; Yosuke Inaba, PhD16; Hideki Hanaoka, MD, PhD16; Kei Ikeda, MD, PhD1; Hiroshi Nakajima, MD, PhD1; for the LoVAS Collaborators
doi : 10.1001/jama.2021.6615
JAMA. 2021;325(21):2178-2187
Importance The current standard induction therapy for antineutrophil cytoplasm antibody (ANCA)–associated vasculitis is the combination of high-dose glucocorticoids and cyclophosphamide or rituximab. Although these regimens have high remission rates, they are associated with considerable adverse events presumably due to high-dose glucocorticoids.
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky, MD, PhD1; William A. Werbel, MD2; Robin K. Avery, MD2; Aaron A. R. Tobian, MD, PhD3; Allan B. Massie, PhD1; Dorry L. Segev, MD, PhD1; Jacqueline M. Garonzik-Wang, MD, PhD1
doi : 10.1001/jama.2021.7489
JAMA. 2021;325(21):2204-2206
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US
Bradley D. Stein, MD, PhD1; Brendan Saloner, PhD2; Megan S. Schuler, PhD3; Jill Gurvey, MPH3; Mark Sorbero, MS1; Adam J. Gordon, MD, MPH4
doi : 10.1001/jama.2021.4469
JAMA. 2021;325(21):2206-2208
Reconceptualizing How to Support Surrogates Making Medical Decisions for Critically Ill Patients
J. Nicholas Dionne-Odom, PhD, RN1; Douglas B. White, MD, MAS2
doi : 10.1001/jama.2021.6445
JAMA. 2021;325(21):2147-2148
Implementing Measurement Science for Electronic Health Record Use
Edward R. Melnick, MD, MHS1,2; Christine A. Sinsky, MD3; Harlan M. Krumholz, MD, SM4,5
doi : 10.1001/jama.2021.5487
JAMA. 2021;325(21):2149-2150
An Evolving Hospital Quality Star Rating System From CMS
Karl Y. Bilimoria, MD, MS1,2; Cynthia Barnard, PhD, MBA1,2
doi : 10.1001/jama.2021.6946
JAMA. 2021;325(21):2151-2152
Does Sleep Flush Wastes From the Brain?
Anthony L. Komaroff, MD1
doi : 10.1001/jama.2021.5631
JAMA. 2021;325(21):2153-2155
The Challenge of Knowing
Jessica Kalender-Rich, MD1
doi : 10.1001/jama.2021.7850
JAMA. 2021;325(21):2155-2156
Detection of Subclinical Atrial Fibrillation After Stroke
David Tirschwell, MD, MSc1; Nazem Akoum, MD, MS2
doi : 10.1001/jama.2021.7429
JAMA. 2021;325(21):2157-2159
Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia
Tamar S. Polonsky, MD, MSCI1; Mary M. McDermott, MD2,3
doi : 10.1001/jama.2021.2126
JAMA. 2021;325(21):2188-2198
Importance Lower extremity peripheral artery disease (PAD) affects approximately 8.5 million people in the US and approximately 230 million worldwide.
Mask Mandates, On-Premises Dining, and COVID-19
Gery P. Guy Jr, PhD, MPH1; Greta M. Massetti, PhD1; Erin Sauber-Schatz, PhD, MPH1
doi : 10.1001/jama.2021.5455
JAMA. 2021;325(21):2199-2200
Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines
Johanna Chapin-Bardales, PhD, MPH1; Julianne Gee, MPH1; Tanya Myers, PhD, MSc1
doi : 10.1001/jama.2021.5374
JAMA. 2021;325(21):2201-2202
Lead, Mistrust, and Trauma—Whistleblowing Pediatrician Discusses the Legacy of Flint’s Water Crisis
Jennifer Abbasi
doi : 10.1001/jama.2021.2314
JAMA. 2021;325(21):2136-2139
Start-ups Tout Continuous Glucose Monitoring for People Without Diabetes
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.3789
JAMA. 2021;325(21):2140-2142
Immunotherapy Approved for Endometrial Cancer
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.8319
JAMA. 2021;325(21):2143
Helping Patients Improve Muscle Movement After Stroke
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.7913
JAMA. 2021;325(21):2143
New Naloxone Dosage Is Approved
Rebecca Voelker, MSJ
doi : 10.1001/jama.2021.8320
JAMA. 2021;325(21):2143
Prayer Whistle in the SARS-CoV-2 Ward
Nuria M. Pastor-Soler, MD, PhD1
doi : 10.1001/jama.2021.1862
JAMA. 2021;325(21):2213
Atrial Fibrillation
Jayson R. Baman, MD1; Rod S. Passman, MD, MSCE1
doi : 10.1001/jama.2020.23700
JAMA. 2021;325(21):2218
Risks and Benefits of Benzodiazepines
Mark Abie Horowitz, MBBS, PhD1; James M. Wright, MD, PhD2; David Taylor, PhD3
doi : 10.1001/jama.2021.4513
JAMA. 2021;325(21):2208-2209
Risks and Benefits of Benzodiazepines
Utsav Shrestha, MD1; Reena Karnik, MD1; Niva Joshi, BSc2
doi : 10.1001/jama.2021.4516
JAMA. 2021;325(21):2209
Risks and Benefits of Benzodiazepines—Reply
Matthew E. Hirschtritt, MD, MPH1; Mark Olfson, MD, MPH2; Kurt Kroenke, MD3
doi : 10.1001/jama.2021.4522
JAMA. 2021;325(21):2209-2210
APOE Allele Testing and Alzheimer Disease
Mu-Hong Chen, MD, PhD1; Fu-Chi Yang, MD, PhD2; Chih-Sung Liang, MD3
doi : 10.1001/jama.2021.4919
JAMA. 2021;325(21):2210-2211
APOE Allele Testing and Alzheimer Disease—Reply
Parichita Choudhury, MD, MSc1; Vijay K. Ramanan, MD, PhD1; Bradley F. Boeve, MD1
doi : 10.1001/jama.2021.4925
JAMA. 2021;325(21):2211
